Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study)
Özet
Aim Five years after the first “Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with type 2 Diabetes” (TEMD-1), attainment of glycemic, arterial blood pressure (ABP), and LDL-cholesterol (LDL-C) goals was re-investigated in patients with type 2 diabetes mellitus (T2DM), with an additional focus on therapeutic inertia. Methods This cross-sectional study consecutively enrolled patients from 70 tertiary endocrine centers across Türkiye (November 2022–January 2023). Metabolic targets were HbA1c <7% (<53 mmol/mol), home ABP <135/85 mmHg, and risk-stratified LDL-C <55, <70, or <100 mg/dL (<1.4, <1.8, or <2.6 mmol/L). Therapeutic inertia was defined as failure to intensify treatment at enrollment. Results Among the 4956 participants (mean age: 58.9 ± 10.0 years, women: 59.8%), HbA1c, ABP, LDL-C and triple metabolic control target attainment rates were 36.7%, 71.1%, 8.7%, and 2.8%, respectively. Glycemic control rate was found lower than the previous survey (40.0% vs. 36.7%, p < 0.001), while LDL-C control rate improved (7.0% vs. 8.7%, p = 0.002). Patients with established cardiovascular disease (CVD) showed worse outcomes, with triple metabolic control rate of 1.6%. The rate of severely uncontrolled diabetes (HbA1c >9%/75 mmol/mol) was 23.6%. Therapeutic inertia was observed by 33.5%, persisting uniformly across subgroups. Younger age, male sex, longer diabetes duration, lower socioeconomic status, and microvascular complications were independently associated with poor glycemic control. Conclusions Metabolic control remains suboptimal in Turkish T2DM patients, and one-third of patients with severe hyperglycemia showed therapeutic inertia. Systematic interventions and intensified strategies are urgently needed to improve diabetes outcomes and treatment inertia ( ClinicalTrials.gov number NCT06347445 ).
Anahtar kelimeler
Atıf için künye
Sonmez, A., Haymana, C., Demirci, I., ARSLAN, B., GÖNEN, M. S., Akbas, E. M., Yalin, G. Y., AVCI, U., Tasci, I., Salman, S., ERSOY, C., Bayram, F., Satman, I., Batman, A., Çorakçı, A., SELEK, A., Kırık, A., Tuzcu, A. K., GÖKÇAY CANPOLAT, A., … CANTÜRK, Z. (2026). Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study). Journal of Diabetes and its Complications, 40(9). https://doi.org/10.1016/j.jdiacomp.2026.109348
BibTeX
@article{sonmez2026-71779,
author = {Sonmez, Alper and Haymana, Cem and Demirci, Ibrahim and ARSLAN, BERRİN and GÖNEN, MUSTAFA SAİT and Akbas, Emin Murat and Yalin, Gulsah Yenidunya and AVCI, UĞUR and Tasci, Ilker and Salman, Serpil and ERSOY, CANAN and Bayram, Fahri and Satman, Ilhan and Batman, Adnan and Çorakçı, Ahmet and SELEK, ALEV and Kırık, Ali and Tuzcu, Alpaslan Kemal and GÖKÇAY CANPOLAT, ASENA and Karakoç, Ayhan and AKALIN, AYSEN and Atmaca, Ayşegül and Eraydın, Ayten and Oğuz, Ayten and Tetiker, B. Tamer and Güler, Bağdagül Yüksel and Evren, Bahri and Yılmaz, Banu Aktaş and Ertürk, Banu and Sarıakçalı, Barış and ÇAKIR, BEKİR and Efe, Belgin and Demirbaş, Berrin and YILMAZ BÜLBÜL, BUKET and Andaç, Burak and Kara, Canan Şehit and Anıl, Cüneyd and Köksalan, Damla and Tüfekçi, Damla and Sakız, Davut and Çorapçıoğlu, Demet and Atikcan, Deniz Türküm and Özdemir, Didem and Yavuz, Dilek Gogaz and Tüzün, Dilek and Kan, Elif Kılıç and Baykan, Emine Kartal and Selvi, Emrah and Bozkırlı, Emre and SAYGILI, EMRE SEDAR and Güney, Engin and GÜRKAN, EREN and Çakal, Erman and KARAKILIÇ, ERSEN and Akbay, Esen and Çağıltay, Eylem and Kılınç, Faruk and Kutlutürk, Faruk and Keskin, Fatma Ela and Ünal, Fatma Tuğçe Şah and Öztürk, Feyza Yener and Mısıroğlu, Fuat and Özdemir, Fulya and Küçükgöde, Gizem Ertepe and Kaplan, Gizem Ilgın and YORULMAZ, GÖKNUR and Akbaba, Gülhan and Duman, Gülhan Cavlak and Elbüken, Gülşah and Yaylalı, Güzin Fidan and Bilen, Habib and Pişkinpaşa, Hamide and İlkova, Hasan Mahmut and Öner, Hatice and Özışık, Hatice and Hacişahinoğulları, Hülya and Kaynak, Hülya and Sodan, Hülya Nur and Odluyurt, Hülya and NUHOĞLU, İRFAN and Aslan, İbrahim and Şahin, İbrahim and Yetkin, İlhan and Koçar, İlkcan Çerçi and Ünsal, İlknur Öztürk and Engin, İsmail and Uğur, Kader and Ağbaht, Kemal and Şakar, Kenan and Karşıdag, Kubilay and Özsarı, Levent and Yazıcı, Mahmut and Kebapçı, Medine Nur and Eren, Mehmet Ali and Ünal, Mehmet Çağrı and Süle, Mehmet and Evran, Mehtap and Mert, Meral and Derviş, Mert Adnan and Çatak, Merve and Adaş, Mine and Öztürk, Mine and Mızrak, Mithat and Alay, Murat and Çelik, Murat and Şahin, Murat and Cesur, Mustafa and Eroğlu, Mustafa and Kulaksızoğlu, Mustafa and Kutlu, Mustafa and Ünübol, Mustafa and Yılmaz, Müge Özsan and Eryılmaz, Müzeyyen and Tütüncü, Neslihan Başçıl and ÖZDEMİR, NİLÜFER and Rasulova, Nubar and YILMAZ, NUSRET and Dikbaş, Oğuz and DEYNELİ, Oğuzhan and Dizdar, Oğuzhan Sıtkı and Yıldız, Okan Bülent and Demir, Orhan and Topaloğlu, Ömercan and Gül, Özen Öz and Çaklılı, Özge Telci and Alkan, Özlem and Haliloğlu, Özlem and Meletli, Özlem Kanburoğlu and Akhanlı, Pınar and Köksal, Pınar and Güller, Pınar Üzgeç and Sarı, Ramazan and Emral, Rıfat and Tekin, Sakin and Yıldız, Saliha and Karslı, Seda and Altuntaş, Seher Çetinkaya and Fenkci, Semin M. and Uysal, Serhat and Yener, Serkan and Çiftel, Serpil and Fakı, Sevgül and Güldiken, Sibel and Çağlayan, Sinan and Kıyıcı, Sinem and CANDER, SONER and Baldane, Süleyman and Polat, Şefika Burçak and Topsakal, Şenay and Çetinkalp, Şevki and Bayraktaroğlu, Taner and Yılmaz, Temel and Doğru, Teoman and Sabuncu, Tevfik and Akkan, Tolga and Şen, Tuğba Arslan and Barlas, Tuğba and YUMUK, VOLKAN DEMİRHAN and Günay, Yasemin Emür and Bozkuş, Yusuf and Altuntaş, Yüksel and Pekkolay, Zafer and Kara, Zehra and HEKİMSOY, ZELİHA and Yarar, Zeliha and CANTÜRK, ZEYNEP},
title = {Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study)},
journal = {Journal of Diabetes and its Complications},
year = {2026},
volume = {40},
number = {9},
issn = {1056-8727},
doi = {10.1016/j.jdiacomp.2026.109348},
url = {https://akademik.atauni.edu.tr/yayinlar/71779-turkish-cross-sectional-survey-of-glycemic-and-other-metabolic-parameters-in}
}